Pentoxifylline and vitamin E treatment for prevention of radiation-induced side-effects in women with breast cancer: A phase two, double-blind, placebo-controlled randomised clinical trial (Ptx-5)

European Journal of Cancer

Volumn 45, Issue 14, 2009, Pages 2488-2495

  Magnusson, Marie ^a   Höglund, Peter ^a   Johansson, Karin ^b   Jönsson, Charlotta ^a   Killander, Fredrika ^a   Malmström, Per ^a   Weddig, Anna ^a   Kjellén, Elisabeth ^a,c  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c UMEÅ UNIVERSITY   (Sweden)

Author keywords

Breast cancer; Fibrosis; Lymphoedema; Pentoxifylline; Radiation; Randomised placebo controlled clinical trial; Vitamin E

Indexed keywords

ALPHA TOCOPHEROL; ANASTROZOLE; EXEMESTANE; LETROZOLE; PENTOXIFYLLINE; PLACEBO; TAMOXIFEN;

ADULT; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONJUNCTIVAL HEMORRHAGE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIARRHEA; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEMALE; GASTRITIS; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; INSOMNIA; LYMPHEDEMA; MAJOR CLINICAL STUDY; NAUSEA; NEUROPATHIC PAIN; PATIENT COMPLIANCE; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SWEATING; VOMITING; WEIGHT REDUCTION;

AGED; ANTIOXIDANTS; BREAST NEOPLASMS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MIDDLE AGED; PENTOXIFYLLINE; RADIATION INJURIES; RADIATION-PROTECTIVE AGENTS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, ADJUVANT; SWEDEN; TREATMENT OUTCOME; VITAMIN E;

EID: 69249108200     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.05.015     Document Type: Article

References (27)

1. Register S.C. Breast cancer incidents in Sweden 2006 (2006), National Board of Health and Welfarés Cancer Register
2. Clarke M., Collins R., Darby S., et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366 9503 (2005) 2087-2106
3. Johansson K., Holmstrom H., Nilsson I., Ingvar C., Albertsson M., and Ekdahl C. Breastcancer patientś experiences of lymphoedema. Scand J Caring Sci 17 (2003) 35-42
4. Pyszel A., Malyszczak K., Pyszel K., Andrzejak R., and Szuba A. Disability, psychological distress and quality of life in breast cancer survivors with arm lymphedema. Lymphology 39 4 (2006) 185-192
5. Senkus-Konefka E., and Jassem J. Complications of breast-cancer radiotherapy. Clin Oncol (R Coll Radiol) 18 3 (2006) 229-235
6. Lee T.S., Kilbreath S.L., Refshauge K.M., Herbert R.D., and Beith J.M. Prognosis of the upper limb following surgery and radiation for breast cancer. Breast Cancer Res Treat 110 1 (2008) 19-37
7. Delanian S., Porcher R., Balla-Mekias S., and Lefaix J.L. Randomized, placebo-controlled trial of combined pentoxifylline and tocopherol for regression of superficial radiation-induced fibrosis. J Clin Oncol 21 13 (2003) 2545-2550
8. Moher D., Pham B., Ausejo M., Saenz A., Hood S., and Barber G.G. Pharmacological management of intermittent claudication: a meta-analysis of randomised trials. Drugs 59 5 (2000) 1057-1070
9. Samlaska C.P., and Winfield E.A. Pentoxifylline. J Am Acad Dermatol 30 4 (1994) 603-621
10. Ward A., and Clissold S.P. Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs 34 1 (1987) 50-97
11. Berman B., and Duncan M.R. Pentoxifylline inhibits normal human dermal fibroblast in vitro proliferation, collagen, glycosaminoglycan, and fibronectin production, and increases collagenase activity. J Invest Dermatol 92 4 (1989) 605-610
12. Berman B., and Duncan M.R. Pentoxifylline inhibits the proliferation of human fibroblasts derived from keloid, scleroderma and morphoea skin and their production of collagen, glycosaminoglycans and fibronectin. Br J Dermatol 123 3 (1990) 339-346
13. Delanian S., and Lefaix J.L. The radiation-induced fibroatrophic process: therapeutic perspective via the antioxidant pathway. Radiother Oncol 73 2 (2004) 119-131
14. Rubin P., Constine L.S., Fajardo L.F., Phillips T.L., and Wasserman T.H. RTOG late effects working group. Overview. Late effects of normal tissues (LENT) scoring system. Int J Radiat Oncol Biol Phys 31 5 (1995) 1041-1042
15. Scott J., and Huskisson E.C. Graphic representation of pain. Pain 2 2 (1976) 175-184
16. Bednarczyk J.H., Hershler C., and Cooper D.G. Development and clinical evaluation of a computerized limb volume measurement system (CLEMS). Arch Phys Med Rehabil 73 1 (1992) 60-63
17. Kettle J.H., Rundle F.F., and Oddie T.H. Measurement of upper limb volumes: a clinical method. Aust N Z J Surg 27 4 (1958) 263-270
18. Nicklasson M., Bjorkman S., Roth B., Jonsson M., and Hoglund P. Stereoselective metabolism of pentoxifylline in vitro and in vivo in humans. Chirality 14 8 (2002) 643-652
19. Shah D.A., and Madden L.V. Nonparametric analysis of ordinal data in designed factorial experiments. Phytopathology 94 1 (2004) 33-43
20. Johansson K., Ingvar C., Albertsson M., and Ekdahl C. Arm lymphoedema, shoulder mobility and muscle strength after breast cancer treatment - a prospective 2-year study. Adv Physiother 3 (2001) 55-66
21. Chiao T.B., and Lee A.J. Role of pentoxifylline and vitamin E in attenuation of radiation-induced fibrosis. Ann Pharmacother 39 3 (2005) 516-522
22. Delanian S., Balla-Mekias S., and Lefaix J.L. Striking regression of chronic radiotherapy damage in a clinical trial of combined pentoxifylline and tocopherol. J Clin Oncol 17 10 (1999) 3283-3290
23. Ozturk B., Egehan I., Atavci S., and Kitapci M. Pentoxifylline in prevention of radiation-induced lung toxicity in patients with breast and lung cancer: a double-blind randomized trial. Int J Radiat Oncol Biol Phys 58 1 (2004) 213-219
24. Aygenc E., Celikkanat S., Kaymakci M., Aksaray F., and Ozdem C. Prophylactic effect of pentoxifylline on radiotherapy complications: a clinical study. Otolaryngol Head Neck Surg 130 3 (2004) 351-356
25. Miller III E.R., Pastor-Barriuso R., Dalal D., Riemersma R.A., Appel L.J., and Guallar E. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 142 1 (2005) 37-46
26. Lonn E., Bosch J., Yusuf S., et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 293 11 (2005) 1338-1347
27. Berry D., Wathen J.K., and Newell M. Bayesian model averaging in meta-analysis: vitamin E supplementation and mortality. Clin Trials 6 1 (2009) 28-41